ArticleInternational journal of hematology2005

Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation.

Takehiko Mori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.